Trial Profile
The comparison of alfa glucosidase inhibitor or glinide based DPP-4 inhibitor combination therapy in drug-naive type 2 diabetic patients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Dec 2014
Price :
$35
*
At a glance
- Drugs Alogliptin (Primary) ; Miglitol (Primary) ; Repaglinide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 24 Dec 2014 New trial record